These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9242504)

  • 1. Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption.
    Nishijima T; Tokura Y; Imokawa G; Seo N; Furukawa F; Takigawa M
    J Invest Dermatol; 1997 Aug; 109(2):175-82. PubMed ID: 9242504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute cutaneous barrier perturbation induces maturation of Langerhans' cells in hairless mice.
    Katoh N; Hirano S; Kishimoto S; Yasuno H
    Acta Derm Venereol; 1997 Sep; 77(5):365-9. PubMed ID: 9298129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photohapten TCSA painting plus UVA irradiation of murine skin augments the expression of MHC class II molecules and CD86 on Langerhans cells.
    Nishijima T; Tokura Y; Imokawa G; Takigawa M
    J Dermatol Sci; 1999 Apr; 19(3):202-7. PubMed ID: 10215193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin.
    Onoue A; Kabashima K; Kobayashi M; Mori T; Tokura Y
    Exp Dermatol; 2009 Dec; 18(12):1036-43. PubMed ID: 19558500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells.
    Gerberick GF; Ryan CA; Von Bargen EC; Stuard SB; Ridder GM
    J Invest Dermatol; 1991 Aug; 97(2):210-8. PubMed ID: 1649226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of immune functions in barrier disrupted skin by UVB irradiation.
    Ito T; Seo N; Yagita H; Tsujimura K; Takigawa M; Tokura Y
    J Dermatol Sci; 2003 Dec; 33(3):151-9. PubMed ID: 14643520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
    Katoh N; Hirano S; Kishimoto S; Yasuno H
    Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of cutaneous immune responses by ATP gamma S: purinergic agonists define a novel class of immunologic adjuvants.
    Granstein RD; Ding W; Huang J; Holzer A; Gallo RL; Di Nardo A; Wagner JA
    J Immunol; 2005 Jun; 174(12):7725-31. PubMed ID: 15944274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity.
    Nuriya S; Yagita H; Okumura K; Azuma M
    Int Immunol; 1996 Jun; 8(6):917-26. PubMed ID: 8671681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-presenting cell function of epidermal cells activated by hapten application.
    Nakano Y
    Br J Dermatol; 1998 May; 138(5):786-94. PubMed ID: 9666823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of UVB-sensitive mice to immunosuppressive doses of UVB in vivo fails to affect the accessory function or the phenotype of draining lymph node dendritic cells.
    Lappin MB; Kimber I; Dearman RJ; Norval M
    Exp Dermatol; 1996 Oct; 5(5):286-94. PubMed ID: 8981028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
    Atarashi K; Kabashima K; Akiyama K; Tokura Y
    Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity.
    Nakae S; Naruse-Nakajima C; Sudo K; Horai R; Asano M; Iwakura Y
    Int Immunol; 2001 Dec; 13(12):1471-8. PubMed ID: 11717188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of immune function during the development of the Langerhans cell network in neonatal mice.
    Dewar AL; Doherty KV; Woods GM; Lyons AB; Muller HK
    Immunology; 2001 May; 103(1):61-9. PubMed ID: 11380693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
    Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
    J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
    Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M
    Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitizing capacity of Langerhans' cells obtained from ultraviolet-B-exposed murine skin.
    Dai R; Streilein JW
    Immunology; 1995 Dec; 86(4):661-7. PubMed ID: 8567035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
    Dai R; Grammer SF; Streilein JW
    J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response.
    Kondo H; Ichikawa Y; Imokawa G
    Eur J Immunol; 1998 Mar; 28(3):769-79. PubMed ID: 9541570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrity of the permeability barrier regulates epidermal Langerhans cell density.
    Proksch E; Brasch J; Sterry W
    Br J Dermatol; 1996 Apr; 134(4):630-8. PubMed ID: 8733362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.